Disease progression, drug action and Parkinson's disease: why time cannot be ignored

Eur J Clin Pharmacol. 2008 Feb;64(2):207-16. doi: 10.1007/s00228-007-0427-9. Epub 2007 Dec 19.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antiparkinson Agents / pharmacology
  • Antiparkinson Agents / therapeutic use*
  • Clinical Trials as Topic
  • Disease Progression
  • Humans
  • Levodopa / pharmacology
  • Levodopa / therapeutic use*
  • Models, Biological
  • Parkinson Disease / drug therapy*
  • Time Factors

Substances

  • Antiparkinson Agents
  • Levodopa